Show
Sort by
-
Ultrasound-guided core needle biopsy and incisional biopsy of the parotid gland are comparable in diagnosis of primary Sjögren’s syndrome
-
Selection of study endpoints and patients for clinical trials in primary Sjögren's syndrome
-
The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjögren's syndrome
-
Discriminative power of salivary gland ultrasound in relation to symptom-based endotypes in suspected and definite primary Sjögren's Syndrome
-
Peripheral manifestations are major determinants of disease phenotype and outcome in new onset spondyloarthritis
-
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial
-
Nailfold capillaroscopy in Sjogren's syndrome : a systematic literature review and standardised interpretation
-
- Journal Article
- A1
- open access
Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC) : a structured summary of a study protocol for a randomised controlled trial
-
- Journal Article
- A1
- open access
Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID) : a structured summary of a study protocol for a randomised controlled trial
-
Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID) : a structured summary of a study protocol for a randomised controlled trial (vol 21, 468, 2020)
-
Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC) : a structured summary of a study protocol for a randomised controlled trial (vol 21, 491, 2020)
-
Changing the wolf from outside : how microbiota trigger systemic lupus erythematosus
-
Risks and benefits of corticosteroids in arthritic diseases in the clinic
-
Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope
-
Modeling the probability for rheumatoid arthritis during diagnostic work-up: How to combine the results of ACPA, RF and HLA-SE testing?
-
Mannose-binding lectin (MBL2) polymorphisms in rheumatoid arthritis (RA) are not associated with susceptibility or radiological progression rate
-
Autoantibodies in rheumatology practice : relevance for diagnosis and associations with clinical features
(2005) -
Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor
-
Mannose-binding lectin polymorphisms in rheumatoid arthritis and the associations with radiological progression rate and serological markers
-
Mannose-binding lectin polymorphisms in rheumatoid arthritis and the associations with radiological progression rate and serological markers
-
Mannose-binding lectin (MBL2) polymorphisms in rheumatoid arthritis (RA) are not associated with susceptibility or radiological progression rate
-
Case number 34: Relapse of polyarteritis nodosa presenting as isolated and localised lower limb periostitis
-
Mannose-binding lectin (Mbl2) polymorphisms in rheumatoid arthritis are not associated with susceptibility, radiological progression rate, or serological markers
-
Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
-
Diagnostic performance and predictive value of rheumatoid factor, anti-citrullinated peptide antibodies, and the HLA shared epitope for diagnosis of rheumatoid arthritis
-
History and diagnostic value of antibodies to citrullinated proteins in rheumatoid arthritis
-
Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus
-
Diagnostic performance and predictive value of serum markers for the diagnosis of rheumatoid arthritis
-
False positivity of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosus
-
Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations
-
Cutaneous polyarteritis nodosa: A distinct entity
-
Rheumatoid factor and anti-citrullinated peptide antibodies in rheumatoid arthritis: Diagnostic value and association with radiological progression
-
Presence of anti-RNP-A and anti-RNP-C antibodies is inversely associated with renal symptoms of systemic lupus erythematosus
-
Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the getailed serotype.
-
Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests.
-
Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease.
-
Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing.
-
Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium - Relevance to antifilaggrin autoantibodies.
-
Sensitivity of the HEp-2000 substrate for the detection of Anti-SSA/Ro60 antibodies.
-
Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption.
-
Analysis of the P wave with signal averaging to assess the risk of atrial fibrillation after coronary artery bypass surgery.